{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:00:34Z","timestamp":1784642434034,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ijpharm.2006.02.053","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T11:07:13Z","timestamp":1144408033000},"page":"124-130","source":"Crossref","is-referenced-by-count":24,"title":["Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant"],"prefix":"10.1016","volume":"316","author":[{"given":"Shinya","family":"Takatsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Koguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Horikiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.02.053_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jps.2600840604","article-title":"Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine","volume":"84","author":"Asada","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib3","first-page":"361","article-title":"Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration","volume":"2","author":"Bernkop-Schn\u00fcrch","year":"1996","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.02.053_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/014860719602000298","article-title":"Adhesive mucous gel layer and mucus release as intestinal barrier in rats","volume":"20","author":"Iiboshi","year":"1996","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","article-title":"Polysaccharide colloidal particles as delivery systems for macromolecules","volume":"47","author":"Janes","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1055\/s-2004-835837","article-title":"Effects of ursolic acid, betulin and sulfur-containing compounds on micin release from airway goblet cells","volume":"70","author":"Lee","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0169-409X(89)90018-5","article-title":"Penetration and enzymatic barriers to peptide and protein absorption","volume":"4","author":"Lee","year":"1990","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib9","first-page":"91","article-title":"Mucosal penetration enhancers for facilitation of peptide and protein drug absorption","volume":"8","author":"Lee","year":"1991","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1023\/A:1014849630520","article-title":"Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs","volume":"16","author":"Lee","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0928-0987(99)00093-7","article-title":"Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine","volume":"10","author":"Michael","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1056-8719(94)00060-H","article-title":"Evaluation of mucosal damage of surfactants in rat jejunum and colon","volume":"33","author":"Oberle","year":"1995","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ijpharm.2006.02.053_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1248\/bpb.21.615","article-title":"Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers","volume":"21","author":"Quan","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.2042-7158.1998.tb03319.x","article-title":"Cytotoxicity of absorption enhancers in Caco-2 cell monolayers","volume":"50","author":"Sakai","year":"1998","journal-title":"J. Pharm. Pharmcol."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(00)00119-8","article-title":"Design of nanoparticles composed of graft copolymers for oral peptide delivery","volume":"47","author":"Sakuma","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1018819012405","article-title":"Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In vitro permeability and in vivo oral absorption of salmon calcitonin (SCT)","volume":"16","author":"Sinko","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib17","first-page":"39","article-title":"Intestinal permeability enhancement for proteins, peptides, and other polar drugs: mechanisms and potential toxicity","volume":"8","author":"Swenson","year":"1992","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1023\/A:1018920728800","article-title":"Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2004.08.006","article-title":"Characterization of the influence of nitric oxide donors on intestinal absorption of macromolecules","volume":"286","author":"Takahashi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2005.07.008","article-title":"Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant","volume":"62","author":"Takatsuka","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(01)00231-9","article-title":"Oral drug absorption enhancement by chitosan and its derivatives","volume":"52","author":"Thanou","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0142-9612(00)00011-9","article-title":"Transmucosal delivery system for calcitonin: a review","volume":"21","author":"Torres-Lugo","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2006.02.053_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0168-3659(03)00008-7","article-title":"Reversible lipidization for the oral delivery of salmon calcitonin","volume":"88","author":"Wang","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.02.053_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.2042-7158.1996.tb03937.x","article-title":"Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane","volume":"48","author":"Yamamoto","year":"1996","journal-title":"J. Pharm. Pharmcol."},{"key":"10.1016\/j.ijpharm.2006.02.053_bib26","first-page":"84","article-title":"Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs","volume":"296","author":"Yamamoto","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T05:56:07Z","timestamp":1547704567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0378517306001852"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.02.053","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}